Table 4.
Patient characteristics of breast cancer
| Total | Success | Fail | p-value | |
|---|---|---|---|---|
| No. (%) | 10 | 2 (20.0) | 8 (80.0) | |
| Age (yr), median (range) | 59 (47–72) | 47 (47–47) | 61 (54–72) | < 0.001 |
| Sample type | ||||
| Pleural effusion | 10 | 2 (20.0) | 8 (80.0) | |
| Cytopathology | ||||
| Positive | 5 | 2 (40.0) | 3 (60.0) | 0.444 |
| Negative | 5 | 0 | 5 (100) | |
| Clinical subtype | ||||
| HR+ | 2 | 0 | 2 (100) | 0.289 |
| HR+ HER2+ | 3 | 0 | 3 (100) | |
| HER2+ | 1 | 1 (100) | 0 | |
| TNBC | 4 | 1 (25.0) | 3 (75.0) | |
| Ki67 index (%) | ||||
| < 14 | 2 | 0 | 2 (100) | > 0.99 |
| ≥14 | 7 | 2 (28.6) | 5 (71.4) | |
| N/A | 1 | 0 | 1 (100) | |
Values are presented as number (%) unless otherwise indicated. HER2, human epidermal growth factor receptor 2; HR, hormone receptor; N/A, not available; TNBC, triple-negative breast cancer.